Target Name: BSPRY
NCBI ID: G54836
Review Report on BSPRY Target / Biomarker Content of Review Report on BSPRY Target / Biomarker
BSPRY
Other Name(s): Zetin 1 | zetin 1 | B-box and SPRY domain containing | BSPRY_HUMAN | B box and SPRY domain-containing protein | BSPRY variant 2 | B-box and SPRY domain containing, transcript variant 2 | B-box and SPRY-domain containing protein | B box and SPRY domain-containing protein (isoform 2)

BSPRY: A Promising Drug Target / Biomarker

The BSRY gene is located on chromosome 18 and encodes for the protein BSRY. BSRY is a protein that is expressed in many tissues of the body, including the brain, heart, liver, and kidney. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues. The BSRY gene has also been implicated in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Drug Targeting

BSRY is a drug target that has been targeted for several years due to its involvement in several diseases. One of the main goals of drug targeting is to identify drugs that can inhibit the activity of a protein and prevent it from causing harm to the body. BSRY is a protein that is involved in many different processes in the body, making it an attractive target for drug developers.

BSRY has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. In cancer, BSRY has been shown to promote the growth and survival of cancer cells. In neurodegenerative diseases, BSRY has been shown to contribute to the degenerative changes that occur in the brain. In autoimmune diseases, BSRY has been shown to play a role in the development of inflammation and autoimmune responses.

BSRY is also a protein that is involved in the development and maintenance of tissues. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues such as the brain, heart, liver, and kidney. This makes BSRY an attractive target for drugs that can promote tissue growth and development, as well as those that can prevent the degenerative changes that occur in tissues.

BSRY has also been shown to play a role in several other processes in the body, including cell signaling, cell migration, and cell adhesion. This makes it an attractive target for drugs that can inhibit these processes and prevent the development of certain diseases.

BSRY Genetics

BSRY is a gene that has been studied extensively in the context of several diseases. It is located on chromosome 18 and has been shown to encode for a protein that is involved in the regulation of cell growth and differentiation. BSRY has also been shown to play a role in the development and maintenance of tissues, as well as several other processes in the body.

Studies have shown that BSRY is involved in the regulation of cell growth and differentiation, as well as the development and maintenance of tissues. It is a key regulator of cell signaling, cell migration, and cell adhesion. BSRY has also been shown to contribute to the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

BSRY is a gene that has been studied extensively in the context of several diseases. It is located on chromosome 18 and has been shown to encode for a protein that is involved in the regulation of cell growth and differentiation, as well as the development and maintenance of tissues. BSRY is a key regulator of cell signaling, cell migration, and cell adhesion, and has been shown to contribute to the development and progression of several diseases.

Protein Name: B-box And SPRY Domain Containing

Functions: May regulate epithelial calcium transport by inhibiting TRPV5 activity

The "BSPRY Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BSPRY comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BST1 | BST2 | BSX | BTAF1 | BTBD1 | BTBD10 | BTBD16 | BTBD17 | BTBD18 | BTBD19 | BTBD2 | BTBD3 | BTBD6 | BTBD7 | BTBD8 | BTBD9 | BTC | BTD | BTF3 | BTF3L4 | BTF3P11 | BTF3P7 | BTF3P9 | BTG1 | BTG2 | BTG2-DT | BTG3 | BTG4 | BTK | BTLA | BTN1A1 | BTN2A1 | BTN2A2 | BTN2A3P | BTN3A1 | BTN3A2 | BTN3A3 | BTNL10P | BTNL2 | BTNL3 | BTNL8 | BTNL9 | BTRC | BUB1 | BUB1B | BUB1B-PAK6 | BUB3 | BUD13 | BUD23 | BUD31 | Butyrophilin | Butyrophilin subfamily 3 member A (BTN3A) | BVES | BVES-AS1 | BYSL | BZW1 | BZW1-AS1 | BZW1P2 | BZW2 | C-C chemokine receptor | C10orf105 | C10orf113 | C10orf120 | C10orf126 | C10orf143 | C10orf53 | C10orf55 | C10orf62 | C10orf67 | C10orf71 | C10orf71-AS1 | C10orf82 | C10orf88 | C10orf88B | C10orf90 | C10orf95 | C10orf95-AS1 | C11orf16 | C11orf21 | C11orf24 | C11orf40 | C11orf42 | C11orf52 | C11orf54 | C11orf58 | C11orf65 | C11orf68 | C11orf71 | C11orf80 | C11orf86 | C11orf87 | C11orf91 | C11orf96 | C11orf97 | C11orf98 | C12orf29 | C12orf4 | C12orf40 | C12orf42 | C12orf43